The effect of ethnicity on biochemical disease-free outcome in patients with prostate cancer treated with definitive radiation therapy in an equal-access health care system

被引：0
|
作者：
Johnstone, PA
Kane, C
Sun, L
Wu, H
Moul, J
Amling, C
机构：
来源：
RADIOLOGY | 2001年 / 221卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：224 / 225
页数：2
相关论文
共 33 条
  • [21] Correlation of Long-term Biochemical and Distant Metastases Outcome With Posttreatment Biopsy Results for Patients Treated With External Beam Radiation Therapy for Prostate Cancer
    Zelefsky, M. J.
    Kollmeier, M. A.
    McBride, S. M.
    Pei, X.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E247 - E247
  • [22] Changes in biochemical disease-free survival rates as a result of adoption of the consensus conference definition in patients with clinically localized prostate cancer treated with external-beam radiotherapy
    Ennis, RD
    Malyszko, BK
    Heitjan, DF
    Rubin, MA
    O'Toole, KM
    Schiff, PB
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (03): : 511 - 517
  • [23] Propensity score matched analysis of metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy or radical prostatectomy.
    Meeks, Marshall
    Markovina, Stephanie Subasic
    Vetter, Joel
    Paradis, Alethea
    Michalski, Jeff M.
    Sandhu, Gurdarshan Singh
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [24] Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: A propensity score-matched analysis
    Markovina, Stephanie
    Meeks, Marshall W.
    Badiyan, Shahed
    Vetter, Joel
    Gay, Hiram A.
    Paradis, Alethea
    Michalski, Jeff
    Sandhu, Gurdarshan
    [J]. ADVANCES IN RADIATION ONCOLOGY, 2018, 3 (02) : 190 - 196
  • [25] ASSESSING RACIAL DISPARITIES IN LOW AND FAVORABLE INTERMEDIATE RISK PROSTATE CANCER PATIENTS OVER A 27-YEAR PERIOD TREATED WITH EXTERNAL BEAM RADIATION THERAPY IN A RACIALLY DIVERSE, EQUAL ACCESS MILITARY HEALTHCARE SYSTEM
    Stroup, Sean
    Robertson, Audry
    Onofaro, Kayla
    Santomauro, Michael
    Rocco, Nicholas
    Kuo, Huai-ching
    Chaurasia, Avinash
    Rosner, Inger
    Brand, Timothy
    Musser, John
    Porter, Christopher
    Lu-Yao, Grace
    D'Amico, Anthony
    Cullen, Jennifer
    [J]. JOURNAL OF UROLOGY, 2020, 203 : E782 - E782
  • [26] Long-Term Experience in an Equal Access Health Care System Using Moderately Hypofractionated Radiotherapy for High Risk Prostate Cancer in a Predominately African American Population With Unfavorable Disease
    Carpenter, D. J.
    Natesan, D.
    Floyd, W.
    Niedzwiecki, D.
    Waters, L.
    Godfrey, D. J.
    Moravan, M. J., Jr.
    Lee, W. R.
    Salama, J. K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E417 - E417
  • [27] Loss of Tumor Suppressor DAB2IP Correlates With Decreased Biochemical Recurrence-free Survival in High-Risk Prostate Cancer Patients Treated With Radiation Therapy
    Kim, D.
    Tumati, V.
    Pistenmaa, D.
    Kapur, P.
    Xie, X.
    Hannan, R.
    Jacobs, C.
    Straka, C.
    Hsieh, J.
    Saha, D.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S714 - S714
  • [28] Using a surgical prostate-specific antigen threshold of >0.2 ng/mL to define biochemical failure for intermediate- and high-risk prostate cancer patients treated with definitive radiation therapy in the ASCENDE-RT randomized control trial
    Morris, W. James
    Pickles, Tom
    Keyes, Mira
    [J]. BRACHYTHERAPY, 2018, 17 (06) : 837 - 844
  • [29] Changes in biochemical disease-free survival rates as a result of adoption of the consensus conference definition in patients with clinically localized prostate cancer treated with external-beam radiotherapy. (vol 41, pg 511, 1998)
    Ennis, RD
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (02): : 467 - 467
  • [30] Significant interaction between testosterone recovery (TR) and biochemical progression-free survival (BPFS) in intermediate and high-risk patients with prostate cancer treated with radiation therapy (RT) and androgen deprivation therapy (ADT)
    Shasha, D.
    Nabhani, T.
    Rauth, S. J.
    Salant, R.
    Harrison, L. B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
1234